Quick Answer
CollPlant Biotechnologies Ltd reported Stockholders Equity of $6.08 million for fiscal year 2025.
CollPlant Biotechnologies Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.08M | -54.8% |
| 2024 | $13.46M | -52.5% |
| 2023 | $28.34M | -12.2% |
| 2022 | $32.28M | -28.5% |
| 2021 | $45.12M | +907.8% |
| 2020 | $4.48M | +9.5% |
| 2019 | $4.09M | -24.6% |
| 2018 | $5.42M | +4.8% |
| 2017 | $5.17M | — |
- CollPlant Biotechnologies Ltd showed a decrease of -54.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, CollPlant Biotechnologies Ltd’s stockholders equity has grown by 17.6% (from $5.17 million to $6.08 million).
- The most recent figure is from CollPlant Biotechnologies Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: